Published in J Cell Mol Med on February 28, 2013
Gene-Specific Methylation Analysis in Thymomas of Patients with Myasthenia Gravis. Int J Mol Sci (2016) 0.75
A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era. PLoS One (2014) 0.75
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet (1995) 17.27
The history of cancer epigenetics. Nat Rev Cancer (2004) 14.38
Human papillomavirus and cervical cancer. Lancet (2007) 12.47
Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol (1977) 5.21
Epigenetics: regulation through repression. Science (1999) 4.57
A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A (2002) 4.22
Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res (2004) 2.29
Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing. PLoS One (2011) 2.16
Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA (1989) 2.09
A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res (1996) 2.03
Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A (2001) 1.93
Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr (1999) 1.68
Identification of novel DNA methylation markers in cervical cancer. Int J Cancer (2008) 1.42
A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther (2010) 1.20
Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol (2005) 1.18
Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. J Gen Virol (1999) 1.16
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet (2005) 1.15
MTHFR promoter hypermethylation in testicular biopsies of patients with non-obstructive azoospermia: the role of epigenetics in male infertility. Hum Reprod (2009) 1.07
Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. Int J Cancer (2007) 1.06
Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer (2001) 1.06
Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors. BMC Cancer (2007) 1.06
Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur J Cancer (2000) 1.04
Hypomethylation in cervical tissue: is there a correlation with folate status? Cancer Epidemiol Biomarkers Prev (1998) 1.00
Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol (1990) 1.00
Association of MTHFR gene polymorphisms with breast cancer survival. BMC Cancer (2006) 0.98
Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control (2007) 0.97
Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev (2001) 0.92
Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett (2003) 0.89
MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients. Leuk Res (2007) 0.88
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3. Br J Cancer (2003) 0.86
Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate (2000) 0.85
The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine. Cancer Epidemiol Biomarkers Prev (2000) 0.85
Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. Int J Gynecol Cancer (2010) 0.84
MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer. J Gastrointestin Liver Dis (2007) 0.81
Association between gene expression of metabolizing enzymes and esophageal squamous cell carcinomas in China. Genet Test Mol Biomarkers (2012) 0.80
MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies. Prostate Cancer Prostatic Dis (2012) 0.79
The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis. BMC Cancer (2012) 0.79
Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis. PLoS One (2012) 0.76
Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis. Mol Biol Rep (2012) 0.76
Preclinical studies on the mechanism of action and the anti-lymphoma activity of the novel anti-CD20 antibody GA101. Mol Cancer Ther (2011) 1.33
High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia. PLoS One (2012) 0.99
In vivo model of follicular lymphoma resistant to rituximab. Clin Cancer Res (2009) 0.99
Targeting dexamethasone to macrophages in a porcine endotoxemic model. Crit Care Med (2013) 0.88
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study. Cytometry B Clin Cytom (2014) 0.87
The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors. Rom J Morphol Embryol (2012) 0.86
The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case-control study. Eur J Obstet Gynecol Reprod Biol (2010) 0.86
Bortezomib influences the expression of malignant plasma cells membrane antigens. Eur J Pharmacol (2013) 0.85
Immunocytochemical expression of p16INK4a and HPV L1 capsid proteins as predictive markers of the cervical lesions progression risk. Rom J Morphol Embryol (2010) 0.85
TGF-beta signalling pathway factors in HPV-induced cervical lesions. Roum Arch Microbiol Immunol (2011) 0.84
Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience. Cancer (2008) 0.83
Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis. Mol Med Rep (2010) 0.83
Bacteriological agents which play a role in the development of infertility. Acta Microbiol Immunol Hung (2013) 0.81
[Histopathologic and immunohistochemic changes in Helicobacter pylori colonised gastric mucosa]. Rev Med Chir Soc Med Nat Iasi (2011) 0.78
The relationship between HPV16 and HPV18 viral load and cervical lesions progression. Roum Arch Microbiol Immunol (2010) 0.78
Investigation of Th1/Th2 cytokine profiles in patients with laryngo-pharyngeal, HPV-positive cancers. Eur Arch Otorhinolaryngol (2012) 0.78
Resveratrol modulates apoptosis in 5-fluorouracyl treated colon cancer cell lines. Roum Arch Microbiol Immunol (2014) 0.77
[Evaluation of p16INK4a and Ki-67 proteins expression in cervical intraepithelial neoplasia and their correlation with HPV-HR infection]. Rev Med Chir Soc Med Nat Iasi (2011) 0.76
The prevalence of some bacterial markers in female patients undergoing an initial infertility evaluation in north-east Romania. Roum Arch Microbiol Immunol (2010) 0.76
Mitochondrial DNA mutations in patients with HRHPV-related cervical lesions. Roum Arch Microbiol Immunol (2011) 0.76
Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868. Cancer Chemother Pharmacol (2010) 0.76
Hydrocephalus secondary to chemotherapy in a case of prenatally diagnosed giant immature grade 3 sacrococcygeal teratoma: A case report and literature review. Medicine (Baltimore) (2016) 0.75
Type-specific human papillomavirus detection in cervical smears in Romania. APMIS (2010) 0.75
Endothelial cells from hematopoietic stem cells are functionally different from those of human umbilical vein. J Cell Mol Med (2004) 0.75
[Prenatal diagnostic of congenital unilateral hydronephrosis with megaureter--a case presentation]. Rev Med Chir Soc Med Nat Iasi (2007) 0.75
This is not an erythroblast. Blood (2015) 0.75
[Non-traumatic rhabdomyolysis in medical practice]. Rev Med Chir Soc Med Nat Iasi (2010) 0.75
THE PERFORMANCE OF A RAPID TEST FOR ANTI-HCV SCREENING IN ORAL FLUIDS. Roum Arch Microbiol Immunol (2016) 0.75
K-ras expression--marker of dysplasia and cancer. Roum Arch Microbiol Immunol (2010) 0.75
Pelvic endometriosis and uretero-hydronephrosis: clinical, imagistic and surgical implications--case report. Rev Med Chir Soc Med Nat Iasi (2015) 0.75
[Large ovarian cyst associated with pregnancy. Case report]. Rev Med Chir Soc Med Nat Iasi (2010) 0.75
Minimally differentiated acute myeloid leukemia (FAB AML-M0): prognostic factors and treatment effects on survival--a retrospective study of 42 adult cases. Leuk Res (2011) 0.75
The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports. Roum Arch Microbiol Immunol (2013) 0.75
Comparative methods for genotyping hepatitis C virus isolates from Romania. Roum Arch Microbiol Immunol (2010) 0.75
Laparoscopy versus laparotomy for pelvic and lumbar-aortic lymphadenectomy. A 11-year experience. Rev Med Chir Soc Med Nat Iasi (2006) 0.75
[Medical treatment of endometriosis. An update]. Rev Med Chir Soc Med Nat Iasi (2011) 0.75
IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA. Rev Med Chir Soc Med Nat Iasi (2016) 0.75
[Prenatal diagnosis and management of laparoschisis. Case report]. Rev Med Chir Soc Med Nat Iasi (2005) 0.75
GIANT INTRALIGAMENTARY UTERINE LEIOMYOMA AND ITS COMPLICATIONS. Rev Med Chir Soc Med Nat Iasi (2016) 0.75
[The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma]. Rev Med Chir Soc Med Nat Iasi (2004) 0.75
Past experience of SUUB's Pathology Department in classic based cervico-vaginal cytology. Rom J Morphol Embryol (2009) 0.75
MICRORNA BIOGENESIS AND ITS ROLE IN HIV-1 INFECTION. Roum Arch Microbiol Immunol (2015) 0.75
The role of EEG brain mapping in quantification of brain damage in hypertensive disease associated with pregnancy. Rev Med Chir Soc Med Nat Iasi (2012) 0.75
Clinico-epidemiological study of endometrial hyperplasia--a risk factor for the development of endometrial carcinoma? Rev Med Chir Soc Med Nat Iasi (2015) 0.75
Epidemiology and pathology of parotid tumors five-year retrospective study. Rev Med Chir Soc Med Nat Iasi (2015) 0.75
COMPARISONS BETWEEN THE NON-PROLIFERATIVE AND PROLIFERATIVE THERAPY IN FIBROCYSTIC MASTOSIS. Rev Med Chir Soc Med Nat Iasi (2016) 0.75
Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients. Arch Virol (2014) 0.75
The prenatal detection of Jeune syndrome (asphyxiating thoracic dystrophy). Case report. Rev Med Chir Soc Med Nat Iasi (2009) 0.75
Self-oocyte activation and parthenogenesis: an unusual outcome of a misconducted IVF cycle. Gynecol Endocrinol (2015) 0.75
Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study. Cytometry B Clin Cytom (2011) 0.75
Tracking down of laryngo-pharyngeal metastasis. Roum Arch Microbiol Immunol (2011) 0.75
Antenatal incomplete rupture of the umbilical cord. A case report. Rev Med Chir Soc Med Nat Iasi (2005) 0.75
Prenatal diagnosis of gonosomal anomalies: limitations of the FISH method and genetic counseling difficulties in 15 cases. Rev Med Chir Soc Med Nat Iasi (2013) 0.75
The development of larger cells that spontaneously escape senescence--a step during the immortalization of a human cancer cell line. J Cell Mol Med (2004) 0.75
E5HPV16 mRNA EXPRESSION PATTERN ANALYSIS IN PATIENTS WITH CERVICAL LESIONS IN VIRAL STATUS CONTEXT. Roum Arch Microbiol Immunol (2016) 0.75
Benign breast disease and the risk of breast cancer in the next 15 years. Rev Med Chir Soc Med Nat Iasi (2015) 0.75
Cloning and expression of the L1 major capsid protein of the human papillomavirus 18 in murine cells. Int J Mol Med (2003) 0.75
[ASCUS of metaplastic type. Cyto-histopathological correlations]. Rev Med Chir Soc Med Nat Iasi (2005) 0.75
P16INK4A--A possible marker in HPV persistence screening. Roum Arch Microbiol Immunol (2010) 0.75
INTRAUTERINE GROWTH RESTRICTION--PREDICTIVE SERUM MARKERS. Rev Med Chir Soc Med Nat Iasi (2016) 0.75